23
DBS – Process & Review GHANSHYAM

DBS – Process & Review

  • Upload
    vienna

  • View
    30

  • Download
    0

Embed Size (px)

DESCRIPTION

DBS – Process & Review. GHANSHYAM. 3Rs. No need to explain……………. What is DBS?. DBS is a technology used since decades but only in the last five years it been considered for routine blood analysis. - PowerPoint PPT Presentation

Citation preview

Page 1: DBS – Process & Review

DBS – Process & Review

GHANSHYAM

Page 2: DBS – Process & Review

3Rs No need to explain……………

GOALIS

ANIMAL SAVING

R1REPLACEMENT

R2REFINEMENT

R3REDUCTION

Page 3: DBS – Process & Review

What is DBS?

DBS is a technology used since decades but only in the last five years it been considered for routine blood analysis.

It was first introduced by Guthrie et al. in 1963 in the context of neonatal screening of phenylketonurea

Dried Blood Spot (DBS) is a technology that can be used to determine drug concentration in PK/TK studies from whole blood.

Page 4: DBS – Process & Review

Guideline Support

ICH S3A says ….

“The quantification of systemic exposure provides an assessment of the burden on the test species and assists in the interpretation of similarities and differences in toxicity across species, dose groups and sexes. The exposure might be represented by plasma (serum or blood) concentrations or the AUCs of parent compound and/or metabolite(s).”

….…The choice of analyte and the matrix to be assayed (biological fluids or tissue) should be stated and possible interference by endogenous components in each type of sample (from each species) should be investigated. Plasma, serum or whole blood are normally the matrices of choice for toxicokinetic studies”

Page 5: DBS – Process & Review

Advantages of DBS

Smaller blood volume required Less sample processing

No centrifugation No storage/transfer at frozen temperature Less animals required

30% less rat – no separate TK animals are required 60% less mice in serial blood collection in TK Less API, Man-power, Food etc.

Stress due to blood loss can be reduced Vd can be managed well.

Page 6: DBS – Process & Review

Blood Collection and Sampling

Blood sampling by different routes, by different tools is been tested by different researchers.

Typically, routine sampling techniques should be adapted and validated for NCE’s.

Page 7: DBS – Process & Review

Blood Collection and Sampling

Aliquot 15μL blood per spot 3 spots per sample plus ‘spare’ Using a pipette or capillary

Page 8: DBS – Process & Review

Drying Dry for approx 2 hours at room temperature Humidity level may interfere in drying – May take longer duration Ready for ship and/or store in sealable bags containing desiccant

Page 9: DBS – Process & Review

If Shipping Required

Samples classified as “non-hazardous” for shipping

The dried filter papers can be shipped at ambient conditions with a simple envelope and in a plastic pouch and preferably with some desiccant material.

CDC (Centre for Disease Control and Prevention) "Guidelines for the Shipment of Dried Blood Spot Specimens" state that dried spots can be transported via normal postal systems without special mailing cartons.

Page 10: DBS – Process & Review

Punching of Cards

Analytical sample obtained by punching small circular disc (typically 3 mm) from centre of DBS Manually Automation – BSD1000

Page 11: DBS – Process & Review

Sample Processing

Extract disc in organic solvent (typically methanol) containing internal standard

Quantitation by validated LC-MS/MS assay

DBS system from Prolab GmbH

Page 12: DBS – Process & Review

Acetaminophen in Human DBS –On Card Stability

Data of Human DBS on FTA paper stored at room temperature for 113 days.

Nominal Concentration 100 ng/mL 4000 ng/mL Fresh Stored Fresh Stored Mean Concentration (ng/mL) 98.0 96.2 3959.0 3974.3 S.D. 2.0 4.6 54.7 182.2 Precision (%CV) 2.0 4.8 1.4 4.6 Accuracy (% Bias) -2.0 -3.8 -1.0 -0.6 Difference (%) -1.8 0.4

N= 6 replicates

Page 13: DBS – Process & Review

Acetaminophen in Human DBS –10-fold Sample Dilution

10,000 ng/mL sample extracted from card then diluted 10-fold using extract from blank DBS samples (n=6)

Nominal Concentration 10000 ng/mL Mean Concentration (ng/mL) 9347.1 S.D. 337.0 Precision (%CV) 3.6 Accuracy (%Bias) -6.5

Page 14: DBS – Process & Review
Page 15: DBS – Process & Review
Page 16: DBS – Process & Review

No immediate storage is required which will help to preserve the quality of the sample collected.

Issues in plasma drug stability can be resolved

Page 17: DBS – Process & Review

Long term studies (9 animals/sex/dose group in TK) can

be avoided

MNT studies (6 animals/timepoint/dose group/sex)

can be sampled more precisely, more samples per animal

Page 18: DBS – Process & Review

Additionally Main Toxicity animals can be used to collect the blood samples for TK as only 15 µl blood will be required instead of 250 µl)

Page 19: DBS – Process & Review

Help for better correlation of HP data with drug exposure as same animals’ data is available for analysis.

Page 20: DBS – Process & Review

Repeat analysis is possible from same DBS card.

Page 21: DBS – Process & Review

Cost Saving by less API, less food, cage change, man hours etc.

Page 22: DBS – Process & Review

Juvenile Toxicity Studies

Page 23: DBS – Process & Review

To download this presentation please visit To download this presentation please visit http://ghanshyamvaghasiya.wordpress.comhttp://ghanshyamvaghasiya.wordpress.com